Citation: | Ying-xia WANG, Qin HE, Guo-fang WANG, Xuan ZHANG. Expression and Significance of microRNA-21 and EGFR in Non-small Cell Lung Cancer[J]. Journal of Kunming Medical University, 2021, 42(8): 101-105. doi: 10.12259/j.issn.2095-610X.S20210818 |
[1] |
Wen T,Song L,Hua S. Perspectives and controversies regarding the use of natural products for the treatment of lung cancer[J]. Cancer Med,2021,10(7):2396-2422. doi: 10.1002/cam4.3660
|
[2] |
Liu Y,Chen P,Wang H,et al. The landscape of immune checkpoints expression in non-small cell lung cancer:A narrative review[J]. Transl Lung Cancer Res,2021,10(2):1029-1038. doi: 10.21037/tlcr-20-1019
|
[3] |
Sekar D. miRNA 21:A novel biomarker in the treatment of bladder cancer[J]. Biomark Med,2020,14(12):1065-1067. doi: 10.2217/bmm-2020-0319
|
[4] |
Hao B,Zhang J. miRNA-21 inhibition suppresses the human epithelial ovarian cancer by targeting PTEN signal pathway[J]. Saudi J Biol Sci,2019,26(8):2026-2029. doi: 10.1016/j.sjbs.2019.08.008
|
[5] |
Hetta H F,Zahran A M,Shafik E A,et al. Circulating miRNA-21 and miRNA-23a expression signature as potential biomarkers for early detection of non-small-cell lung cancer[J]. Microrna,2019,8(3):206-215. doi: 10.2174/1573399815666190115151500
|
[6] |
Markou A,Zavridou M,Lianidou ES. miRNA-21 as a novel therapeutic target in lung cancer[J]. Lung Cancer (Auckl),2016,7(1):19-27.
|
[7] |
支修益,石远凯,于金明. 中国原发性肺癌诊疗规范(2015年版)[J]. 中华肿瘤杂志,2015,37(1):67-78. doi: 10.3760/cma.j.issn.0253-3766.2015.01.014
|
[8] |
陈希. miRNA与疾病关联预测算法研究[D], 哈尔滨: 哈尔滨工业大学硕士论文, 2018.
|
[9] |
吴艳玲,李升锦. miRNA与呼吸系统疾病关系的研究进展[J]. 世界最新医学信息文摘,2020,20(32):59-60,64.
|
[10] |
殷敏,杜敏,刘彤. 血清miRNA与肺癌的诊断及预后进展[J]. 西南军医,2021,23(1):38-41. doi: 10.3969/j.issn.1672-7193.2021.01.010
|
[11] |
孙站兵,邓伟华,刘艳萍,等. 基于数据库中肺纤维化miRNA及肺癌mRNA芯片资料分析筛查肺癌的潜在治疗靶点[J]. 生命的化学,2021,41(1):133-142.
|
[12] |
Li S,Zeng X,Ma R,et al. MicroRNA-21 promotes the proliferation,migration and invasion of non-small cell lung cancer A549 cells by regulating autophagy activity via AMPK/ULK1 signaling pathway[J]. Exp Ther Med,2018,16(3):2038-2045.
|
[13] |
Zheng W,Zhao J,Tao Y,et al. MicroRNA-21:A promising biomarker for the prognosis and diagnosis of non-small cell lung cancer[J]. Oncol Lett,2018,16(3):2777-2782.
|
[14] |
洪雅敏,涂蓉,尤晓光. 表皮生长因子受体与肿瘤分子成像研究进展[J]. 国际医学放射学杂志,2020,43(5):586-590.
|
[15] |
Wang J X,Wu H L,Zhu M,et al. Role of anti-epidermal growth factor receptor therapy compared with anti-vascular endothelial growth factor therapy for metastatic colorectal cancer:An update meta-analysis of randomized clinical trials[J]. Pathol Oncol Res,2020,26(1):159-166. doi: 10.1007/s12253-017-0365-5
|
[1] | Shengxi YANG, Jiade ZHU, Qiurui LI, Wenlian TU. Clinical Study of Aumolertinib Versus Osimertinib in the Treatment of EGFR-Mutated Advanced Non-Small Cell Lung Cancer. Journal of Kunming Medical University, 2024, 46(): 1-7. |
[2] | Wangxun SHEN, Yinyu YANG, Canwei LI, Jinrong YANG, Sijing WU, Huajun ZHAO, Xiaoyu TUO. Expression and Clinical Significance of ROR1 in Different Histologic Types of Invasive Lung Adenocarcinoma. Journal of Kunming Medical University, 2024, 45(5): 60-65. doi: 10.12259/j.issn.2095-610X.S20240509 |
[3] | Hongxiu YANG, Zhongshan ZHU. Effect of HPRT1 Gene Expression on Overall Survival of Patients with Lung Adenocarcinoma. Journal of Kunming Medical University, 2024, 45(8): 17-23. doi: 10.12259/j.issn.2095-610X.S20240803 |
[4] | Shengqiang YANG, Ping WANG. Effect of Hsp90 Inhibitor Ganetespib Combined with Pemetrexed on Lung Adenocarcinoma Cells. Journal of Kunming Medical University, 2024, 45(7): 30-41. doi: 10.12259/j.issn.2095-610X.S20240705 |
[5] | Fei SONG, Jiayin CHE, Ming HUANG, Dan XU, Hongyang LI, Dingkun LI, Yingying XIANG. The Role of Radioactive Iodine-125 Particles in EMT and Clinical Treatment of Lung Adenocarcinoma. Journal of Kunming Medical University, 2023, 44(1): 140-143. doi: 10.12259/j.issn.2095-610X.S20230101 |
[6] | Bangqing LIU, Jianfeng LI, Xiaohui LIU, Jinnan ZHANG, Jinping LIANG. MiR-196b Promotes Proliferation and Migration of Lung Adenocarcinoma by Targeting ERG. Journal of Kunming Medical University, 2023, 44(10): 83-91. doi: 10.12259/j.issn.2095-610X.S20231023 |
[7] | Jiang WU, He MA, Jinyun JIANG, Na LIU, Ruihuan ZHAO, Yuefeng HE. The Relationship between Arsenic Exposure and DNA Damage of EGFR,PTEN,Kras,and PIK3CA Genes in Arsenic Factory Workers. Journal of Kunming Medical University, 2023, 44(7): 29-33. doi: 10.12259/j.issn.2095-610X.S20230717 |
[8] | Shiqi MA, Yi DING, Min LI, Mengci WANG, Siyu ZHANG, Shumei FENG. LINC00341 Inhibits the Proliferation of Lung Adenocarcinoma Cells Through the MAPK Pathway. Journal of Kunming Medical University, 2023, 44(4): 1-8. doi: 10.12259/j.issn.2095-610X.S20230403 |
[9] | Zhongshan ZHU, Zhou YANG, Chengchuan JIANG, Xiaobing LI, Dou REN, Cheng HUANG, Weiwei ZHANG, Xiangjun LI, Shunli ZHAO. An Analysis of PLA2G1B Expression and Prognosis in Patients with Lung Adenocarcinoma. Journal of Kunming Medical University, 2022, 43(9): 70-76. doi: 10.12259/j.issn.2095-610X.S20220912 |
[10] | Huajun ZHAO, Guoqing PAN, Ying TANG, Zhiyuan WANG, Xiaowei ZHAO, Xiaoyu TUO. Expressions of ROR1 in Lung Adenocarcinoma and Its Relationship with Spread Through Air Apace. Journal of Kunming Medical University, 2022, 43(11): 22-29. doi: 10.12259/j.issn.2095-610X.S20221128 |
[11] | Maofang WU, Yongchun ZHOU, Jingjing CAI, Xin MO, Yinwei LI, Jiahui MAO. EGFR Gene Mutation State and Its Clinical Significance in Multi-nodular Lung Adenocarcinoma in Yunnan Province. Journal of Kunming Medical University, 2022, 43(2): 60-66. doi: 10.12259/j.issn.2095-610X.S20220215 |
[12] | Yan-fen MA, Jian HU, Ning ZHANG, Qian WU, Xiao-qin WANG. Changes and Abnormal Patterns of Coagulation Indicators in Patients with Lung Adenocarcinoma and Tuberculosis Pleural Effusion. Journal of Kunming Medical University, 2021, 42(10): 145-150. doi: 10.12259/j.issn.2095-610X.S20211021 |
[13] | Hong-min DUAN, Nan CHEN, Yong-yan YANG, Yun-xia LI, Jin-xiang FENG, Hang LI, Xiu-wen HUANG, Dong-jin LV, Ming ZHANG, Yu-tao ZHAO. Effects and Mechanism of Anlotinib on Radiosensitivity of Non-small Cell Lung Cancer Cell Lines A549. Journal of Kunming Medical University, 2021, 42(8): 40-46. doi: 10.12259/j.issn.2095-610X.S20210808 |
[14] | Wu Qi Yan , Bian Ge Yuan , Cheng Hui Jun, Li Jiao Xia , Wang Shu Ting , Huang Zhao Lue . . Journal of Kunming Medical University, 2020, 41(09): 32-37. |
[15] | Wang Juan , Su Guo Miao , Pan Guo Qing , Bian Li , Yang Zhe , Zeng Ding Tao . . Journal of Kunming Medical University, 2020, 41(09): 1-6. |
[16] | Zhu Zhong Shan , Yan Wen Hui , Li Xiao Bing , Yang Zhou , Bai Peng . Driver Genes Mutation and Survival Analysis in 200 Patients with Pulmonary Adenocarcinoma Brain Metastasis. Journal of Kunming Medical University, 2018, 39(08): 47-50. |
[17] | Zhong Fang Fang . . Journal of Kunming Medical University, |
[18] | Wang Hua . . Journal of Kunming Medical University, |
[19] | Zhao Chun Fang . . Journal of Kunming Medical University, 2013, 34(01): 1-1. |
[20] | . The Expressions and Significance of ADAM10,EGFR and E-cadherin in Hepatocellular Carcinoma. Journal of Kunming Medical University, |